News from k-v pharmaceutical company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:OGXI)

Jul 27, 2015, 06:00 ET

DNDi and Takeda Collaborate for the Lead Optimization for Aminopyrazole Series for Visceral Leishmaniasis

Drugs for Neglected Diseases initiative (Headquarters: Geneva, Switzerland; Executive Director: Bernard Pécoul, Doctor; "DNDi") and Takeda...

Jun 05, 2015, 17:15 ET

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Takeda Pharmaceutical Company Limited, ("Takeda") today announced additional post-hoc analyses from the global EXAMINE (EXamination of...

May 27, 2015, 07:30 ET
Eli Lilly and Company logo.

Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's 75th Scientific Sessions®

 The presentation of 35 abstracts will demonstrate the breadth and depth of the Boehringer Ingelheim (BIPI) and Eli Lilly and Company (NYSE:...

May 27, 2015, 07:00 ET

Par Pharmaceutical Receives Favorable Appeals Court Ruling in Generic Exelon® Patch Litigation

Par Pharmaceutical Companies, Inc. today announced that the United States Court of Appeals for the Federal Circuit has upheld the U.S. District...

May 26, 2015, 10:19 ET

Par Specialty Pharmaceuticals Launches Cortisporin®-TC Otic Suspension

 Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., today announced the launch of Cortisporin®-TC Otic Suspension...

May 21, 2015, 10:00 ET

Canadians lagging well behind similar countries on access to new medicines: report

OTTAWA, May 21, 2015 /CNW/ - Canadians face wait times of over 460 days in order to get access to new, potentially lifesaving medicines in...

May 15, 2015, 02:26 ET

Takeda Reports Top Line Results in Line With Guidance, With Underlying Growth of +2.8% EPS Affected by One-time Charges in FY2014 Back to Profitable Growth from FY2015 Onward

Operational guidance met  - Underlying revenue +2.8% year-over-year, in line with guidance (reported revenue growing +5.1% to 1,777.8...

May 11, 2015, 08:00 ET

Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV

 Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have furthered their commitment to improve the health of...

May 07, 2015, 09:06 ET

Par Pharmaceutical Announces First Quarter 2015 Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, May 13, 2015 at 10:00 a.m. EDT to review...

Apr 16, 2015, 23:11 ET
Researchers at Takeda and CiRA at Kyoto University, Japan, will collaborate on developing game-changing therapeutics by applying iPS cell and related technologies to pharmaceutical R&D activities, such as drug discovery, cell therapy and drug safety. CiRA Director Shinya Yamanaka, a Nobel laureate for his work on iPS cells, will direct the program, while Takeda provides long-term funding, recommendations on research management, and facilities at Shonan Research Center.

CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research

 Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that...

Apr 14, 2015, 19:00 ET

FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, ("Takeda") today announced that members of the Endocrinologic and...

Apr 13, 2015, 08:40 ET

Takeda Announces Appointment of New President of U.S. Business Unit

 Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA")...

Apr 01, 2015, 08:03 ET

Rx&D responds to PMPRB report: overall impact of medicines must always be considered

OTTAWA, April 1, 2014 /CNW/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) acknowledges the Patented Medicines Prices Review Board's...

Mar 30, 2015, 08:00 ET

Par Specialty Pharmaceuticals Launches Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device Along with Nascobal® Nutrition Direct™ Program

 Par Specialty Pharmaceuticals (formerly Strativa Pharmaceuticals) today announced the launch of Nascobal® Nasal Spray in a single-use...

Mar 27, 2015, 14:08 ET

Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned

MONTREAL, March 27, 2015 /CNW Telbec/ - Russell Williams, President of Canada's Research-Based Pharmaceutical Companies (Rx&D), welcomes the...

Mar 19, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly and Hanmi Announce an Exclusive License and Collaboration Agreement for the Development and Commercialization of an Immunological Therapy

 Eli Lilly and Company (NYSE: LLY) and Hanmi Pharmaceutical Co., Ltd. (Hanmi) today announced they have entered into an exclusive license and...

Mar 09, 2015, 20:20 ET

Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular...

Mar 09, 2015, 13:15 ET

Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology

 Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's...

Mar 06, 2015, 09:00 ET

Par Pharmaceutical Announces Fourth-Quarter and Full-Year 2014 Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, March 13, 2015 at 2:00 p.m. EDT to review...

Feb 10, 2015, 14:12 ET

Rx&D Statement on Mandatory Drug Shortage Reporting

VANCOUVER, Feb. 10, 2015 /CNW/ - Following the Minister of Health's announcement, Russell Williams, President, Canada's Research-Based...